Publications by authors named "Oya Alpar"

Claim this Profile
M
Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination.
Genada Sinani, Melike Sessevmez, M Koray Gök, Saadet Özgümüş, H Oya Alpar

Int J Pharm· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal vaccination with poly(β-amino ester)-poly(d,l-lactide-co-glycolide) hybrid nanoparticles.
Genada Sinani, Melike Sessevmez, M Koray Gök, Saadet Özgümüş, Alper Okyar, H Oya Alpar

Int J Pharm· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.
Erdal Cevher, Stefan K Salomon, Apostolos Makrakis, Xiong Wei Li, Steve Brocchini, H Oya Alpar

J Microencapsul· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: in vivo studies.
Erdal Cevher, Stefan K Salomon, Satyanarayana Somavarapu, Steve Brocchini, H Oya Alpar

J Microencapsul· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.
Elizabeth Cocks, Oya Alpar, Satyanarayana Somavarapu, David Greenleaf

Drug Dev Ind Pharm· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of suspension stabilisers on the delivery of protein-loaded porous poly (DL-lactide-co-glycolide) (PLGA) microparticles via pressurised metered dose inhaler (pMDI).
Elizabeth Cocks, Satyanarayana Somavarapu, Oya Alpar, David Greenleaf

Pharm Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalable DNase I microparticles engineered with biologically active excipients.
Rihab Osman, Khuloud T Al Jamal, Pei-Lee Kan, Gehanne Awad, Nahed Mortada, Oya Alpar

Pulm Pharmacol Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.
Tamara Kusay Jabbar, Eva Calvo-Pinilla, Francisco Mateos, Simon Gubbins, Abdelghani Bin-Tarif, Oya Alpar

PLoS One· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bluetongue virus infection induces aberrant mitosis in mammalian cells.
Andrew E Shaw, Anke Brüning-Richardson, Ewan E Morrison, Jacquelyn Bond, Jennifer Simpson, Oya Alpar

Virol J· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity.
Rihab Osman, Pei Lee Kan, Gehanne Awad, Nahed Mortada, Abd-Elhameed El-Shamy, Oya Alpar

Int J Pharm· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biolistic transfection of human embryonic kidney (HEK) 293 cells.
Xiongwei Li, Masaki Uchida, H Oya Alpar, Peter Mertens

Methods Mol Biol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination.
Rihab Osman, Pei Lee Kan, Gehanne Awad, Nahed Mortada, Abd-Elhameed El-Shamy, Oya Alpar

Int J Pharm· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies.
Richard S Kaye, Tol S Purewal, H Oya Alpar

J Pharm Sci· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.
Burcu Sayin, Satyanarayana Somavarapu, Xiong Wei Li, Dorothea Sesardic, Sevda Senel, Oya H Alpar

Eur J Pharm Sci· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres.
Helena F Florindo, Sreenivas Pandit, Lídia M D Gonçalves, Mafalda Videira, Oya Alpar

Biomaterials· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An investigation into the combination of low frequency ultrasound and liposomes on skin permeability.
Afendi Dahlan, H Oya Alpar, Sudaxshina Murdan

Int J Pharm· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfection by particle bombardment: delivery of plasmid DNA into mammalian cells using gene gun.
Masaki Uchida, Xiong Wei Li, Peter Mertens, H Oya Alpar

Biochim Biophys Acta· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and testing of particulate formulations for the nasal delivery of antibodies.
Richard S Kaye, Tarlochan S Purewal, Oya H Alpar

J Control Release· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Haliza Katas, Erdal Cevher, H Oya Alpar

Int J Pharm· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles.
Man Tsuey Tse, Chris Blatchford, H Oya Alpar

Int J Pharm· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcutaneous immunisation assisted by low-frequency ultrasound.
Afendi Dahlan, H Oya Alpar, Paul Stickings, Dorothea Sesardic, Sudaxshina Murdan

Int J Pharm· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
Haliza Katas, Shu Chen, Adebayo Adetayo Osamuyimen, Erdal Cevher, H Oya Alpar

J Microencapsul· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan.
Sreenivas Pandit, Erdal Cevher, Mohammed Gulrez Zariwala, Satyanarayana Somavarapu, H Oya Alpar

J Microencapsul· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterisation of chitosan nanoparticles for siRNA delivery.
Haliza Katas, H Oya Alpar

J Control Release· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.
Stephen J Elvin, James E Eyles, Kenneth A Howard, Easwaran Ravichandran, Satyanarayan Somavarappu, H Oya Alpar

Vaccine· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis